Publication Cover
Sequential Analysis
Design Methods and Applications
Volume 38, 2019 - Issue 2
120
Views
5
CrossRef citations to date
0
Altmetric
Articles

Adaptive two-stage optimal designs for phase II clinical studies that allow early futility stopping

, &
Pages 199-213 | Received 13 Nov 2017, Accepted 20 Apr 2019, Published online: 09 Jul 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Guogen Shan. (2023) Response adaptive randomization design for a two-stage study with binary response. Journal of Biopharmaceutical Statistics 33:5, pages 575-585.
Read now
Peter Chang, Rongzi Liu, Tingting Hou, Xinyu Yan & Guogen Shan. (2022) Continuity corrected score confidence interval for the difference in proportions in paired data. Journal of Applied Statistics 0:0, pages 1-14.
Read now
Guogen Shan. (2022) Conservative confidence intervals for the intraclass correlation coefficient for clustered binary data. Journal of Applied Statistics 49:10, pages 2535-2549.
Read now
Rezoanoor Rahman & M. Iftakhar Alam. (2022) Stopping for efficacy in single-arm phase II clinical trials. Journal of Applied Statistics 49:10, pages 2447-2466.
Read now
Guogen Shan. (2020) Two-stage optimal designs based on exact variance for a single-arm trial with survival endpoints. Journal of Biopharmaceutical Statistics 30:5, pages 797-805.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.